JACOBS LEVY EQUITY MANAGEMENT, INC - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 272 filers reported holding BLUEBIRD BIO INC in Q4 2020. The put-call ratio across all filers is 1.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$5,598,415
-18.6%
1,841,584
-11.9%
0.03%
-17.5%
Q2 2023$6,879,094
+60.0%
2,090,910
+54.7%
0.04%
+53.8%
Q1 2023$4,299,115
-17.7%
1,351,923
+79.0%
0.03%
-25.7%
Q4 2022$5,225,597
+549.1%
755,144
+493.5%
0.04%
+483.3%
Q3 2022$805,000
+47.7%
127,227
-3.4%
0.01%
+50.0%
Q2 2022$545,000
-71.5%
131,744
-66.6%
0.00%
-69.2%
Q1 2022$1,914,000
-52.3%
394,650
-1.8%
0.01%
-51.9%
Q4 2021$4,016,000
-47.9%
401,985
-0.3%
0.03%
-48.1%
Q3 2021$7,706,000
-70.3%
403,226
-50.2%
0.05%
-70.5%
Q2 2021$25,916,000
+13.6%
810,373
+7.1%
0.18%0.0%
Q1 2021$22,813,000
-3.0%
756,642
+39.2%
0.18%
-14.6%
Q4 2020$23,527,000
+0.4%
543,715
+25.2%
0.21%
-15.2%
Q3 2020$23,436,000
+45.1%
434,396
+64.2%
0.24%
+38.9%
Q2 2020$16,150,000
+176.1%
264,585
+107.9%
0.18%
+133.3%
Q1 2020$5,849,000
+2454.1%
127,267
+9397.5%
0.08%
+1775.0%
Q1 2018$229,0001,3400.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 1,834,965$35,066,0001.72%
Birchview Capital, LP 84,000$1,605,0001.09%
ARMISTICE CAPITAL, LLC 2,472,000$47,240,0000.80%
EcoR1 Capital, LLC 802,507$15,336,0000.53%
Parametrica Management Ltd 36,919$706,0000.53%
Bain Capital Life Sciences Investors, LLC 538,179$7,239,0000.45%
APPLETON GROUP, LLC 19,495$373,0000.32%
MANGROVE PARTNERS IM, LLC 175,587$3,355,0000.30%
Quinn Opportunity Partners LLC 230,100$4,397,0000.28%
PDT Partners, LLC 171,700$3,281,0000.24%
View complete list of BLUEBIRD BIO INC shareholders